Methods for treating airways

Patent metadata

Field	Value
Publication number	US-10278766-B2
Application number	US-201414171973-A
Country	US
Kind code	B2
Filing date	Feb 4, 2014
Priority date	Mar 27, 2000
Publication date	May 7, 2019
Grant date	May 7, 2019

Abstract

This relates to treating airways in a lung to decrease asthmatic symptoms. The also includes steps of measuring a parameter of an airway at a plurality of locations in a lung, identifying at least one treatment site from at least one of the plurality of locations based on the parameter, and applying energy to the treatment site to reduce the ability of the site to narrow.

First claim

The invention claimed is:

1. A method of treating a lung, the method comprising:
stimulating an airway in the lung;
after stimulating the airway, measuring a parameter of the airway;
delivering a liquid to an enclosed volume via an energy delivery device; and
based on the measured parameter, applying energy from an electrode of the energy delivery device, through the enclosed volume of liquid, to tissue surrounding the airway to damage nerve tissue.

2. The method of claim 1 , wherein applying energy includes applying a radio frequency modality, and the energy delivery device is a monopolar device or a bipolar device.

3. The method of claim 1 , further including monitoring electrical impedance of the tissue surrounding the airway.

4. The method of claim 1 , wherein stimulating the airway causes the lung to produce at least one symptom of reversible obstructive pulmonary disease, and stimulating the airway increases the resistance to airflow in the lung or constricts one or more airways in the lung.

5. The method of claim 1 , wherein stimulating the airway includes introducing a pharmacological agent into the airway to induce constriction of the airway.

6. The method of claim 1 , wherein damaging nerve tissue reduces the resistance of the lung to airflow.

7. The method of claim 1 , wherein, after applying energy, the method further includes determining an effectiveness of applying energy by determining whether the lung has a reduced ability to produce at least one symptom of reversible obstructive pulmonary disease.

8. The method of claim 1 , wherein the energy delivery device includes a balloon that prevents the liquid from travelling distal of the energy delivery device within the airway.

9. The method of claim 1 , wherein stimulating the airway and measuring the parameter are both performed with the energy delivery device.

10. A method of treating a lung, the method comprising:
stimulating an airway in the lung to constrict the airway;
after stimulating the airway, measuring a parameter of the airway;
identifying a treatment site based on the measured parameter;
applying energy to the identified treatment site from an electrode, through an enclosed volume of liquid, to damage nerve tissue to reduce the ability of the identified treatment site to respond to a stimulus; and
after applying energy to the identified treatment site, determining an effectiveness of applying energy to the identified treatment site by determining whether the lung has a reduced ability to produce at least one symptom of reversible obstructive pulmonary disease.

11. The method of claim 10 , wherein stimulating the airway includes contacting a portion of the airway with a pharmacological agent to induce constriction of the airway at the contacted portion of the airway, and identifying the treatment site based on the measured parameter includes selecting the contacted portion of the airway to receive energy from the electrode.

12. The method of claim 10 , wherein identifying the treatment site based on the measured parameter includes determining one or more portions of the airway to deliver energy from the electrode.

13. The method of claim 12 , wherein the enclosed volume of liquid is delivered to the airway via an energy delivery device that includes the electrode, and the energy delivery device includes a balloon that prevents the liquid from travelling distal of the energy delivery device within the airway.

14. The method of claim 13 , wherein stimulating the airway and measuring the parameter are both performed with the energy delivery device.

15. A method of treating a lung, the method comprising:
applying one or more diagnostic stimulations to the lung to constrict one or more airways of the lung;
locating one or more treatment sites in the one or more airways of the lung by evaluating a reaction to the diagnostic stimulations; and
damaging nerve tissue via applying energy from an electrode, through an enclosed volume of liquid, in a manner that reduces the ability of the lung to produce a symptom of a lung disease in response to a stimulus.

16. The method of claim 15 , wherein applying diagnostic stimulations to the lung further includes exposing tissue surrounding the one or more airways to an electrical field stimulation.

17. The method of claim 15 , wherein locating the one or more treatment sites further includes measuring an electrical property of tissue surrounding the one or more airways before and after applying the diagnostic stimulations to the lung.

18. The method of claim 15 , wherein the electrode is a radio frequency electrode.

19. The method of claim 15 , wherein applying one or more diagnostic stimulations to the lung further includes introducing a pharmacological agent into the one or more airways to induce constriction of the one or more airways.

20. The method of claim 15 , wherein locating one or more treatment sites includes determining one or more portions of the one or more airways to deliver energy from the electrode.

Assignees

• Asthmatx Inc
• Boston Scient Scimed Inc

Inventors

• Danek Christopher J
• Biggs Michael
• Loomas Bryan E
• Laufer Michael D
• Kaplan Gary S
• Shriner Kelly M
• Wizeman William J

Classifications

• A61B5/0036

  including treatment, e.g., using an implantable medical device, ablating, ventilating · CPC title

• A61B5/4878

  Evaluating oedema · CPC title

• A61B2018/00214

  Expandable means emitting energy, e.g. by elements carried thereon · CPC title

• A61B2017/00106

  ultrasonic · CPC title

• A61B2018/00898

  Alarms or notifications created in response to an abnormal condition · CPC title